| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tivantinib | hepatocyte growth factor receptor | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Liver carcinoma[MeSHID:D006528] |
4.09 | investigational | inhibitor |
| tivantinib | hepatocyte growth factor receptor | small molecule | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Liver carcinoma[MeSHID:D006528] |
4.09 | investigational | unknown |
| tivantinib | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Liver carcinoma[MeSHID:D006528] |
4.09 | phase 3 | inhibitor |
| tivantinib | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Liver carcinoma[MeSHID:D006528] |
4.09 | phase 3 | unknown |
| click here to return to the previous page | ||||||||